Literature DB >> 21934092

MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.

Xiangqiang Liu1, Zhiyong Zhang, Li Sun, Na Chai, Shanhong Tang, Jiang Jin, Hao Hu, Yongzhan Nie, Xin Wang, Kaichun Wu, Haifeng Jin, Daiming Fan.   

Abstract

MicroRNAs (miRNAs) regulate tumor progression and invasion via direct interaction with target messenger RNAs (mRNAs). We defined miRNAs involved in cancer metastasis (metastamirs) using an established in vitro colorectal cancer (CRC) model of minimally metastatic cells (SW480 line) from a colon adenocarcinoma primary lesion and highly metastatic cells (SW620 line) from a metastatic lymph node from the same patient 1 year later. We used microarray analysis to identify miRNAs differentially expressed in SW480 and SW620 cells, focusing on miR-499-5p as a novel candidate prometastatic miRNA whose functions in cancer had not been studied. We confirmed increased miR-499-5p levels in highly invasive CRC cell lines and lymph node-positive CRC specimens. Furthermore, enhancing the expression of miR-499-5p promoted CRC cell migration and invasion in vitro and lung and liver metastasis in vivo, while silencing its expression resulted in reduced migration and invasion. Additionally, we identified FOXO4 and PDCD4 as direct and functional targets of miR-499-5p. Collectively, these findings suggested that miR-499-5p promoted metastasis of CRC cells and may be useful as a new potential therapeutic target for CRC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934092     DOI: 10.1093/carcin/bgr213

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  72 in total

Review 1.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

Review 2.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

3.  Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population.

Authors:  Meili Lv; Wei Dong; Lijuan Li; Lushun Zhang; Xiaowei Su; Li Wang; Linbo Gao; Lin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-02       Impact factor: 4.553

Review 4.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

5.  Programmed cell death factor 4 enhances the chemosensitivity of colorectal cancer cells to Taxol.

Authors:  Daqing Wang; Qianqian Hou; Lingjun Zhao; Jun Gao; Yang Xiao; Anhua Wang
Journal:  Oncol Lett       Date:  2019-05-27       Impact factor: 2.967

Review 6.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

7.  miR-499 rs3746444 polymorphism is associated with cancer development among Asians and related to breast cancer susceptibility.

Authors:  Ping Chen; Jian Zhang; Feng Zhou
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 8.  FOXOs: signalling integrators for homeostasis maintenance.

Authors:  Astrid Eijkelenboom; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-17       Impact factor: 94.444

Review 9.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

10.  miR-617 Promotes the Growth of IL-22-Stimulated Keratinocytes Through Regulating FOXO4 Expression.

Authors:  Tao Liu; Xiaomei Feng; Yongmei Liao
Journal:  Biochem Genet       Date:  2020-11-19       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.